JPS6317850A
(ja)
|
1986-07-11 |
1988-01-25 |
Fuji Photo Film Co Ltd |
3−フエノキシカテコ−ル類の製造方法
|
DK611489A
(da)
|
1988-12-08 |
1990-06-09 |
Duphar Int Res |
Anxiolytisk aktive piperazinderivater og farmaceutiske praeparater med indhold af saadanne forbindelser
|
JPH02255673A
(ja)
|
1989-03-27 |
1990-10-16 |
Fuji Photo Film Co Ltd |
4―アリールオキシー1,3―ベンゾジオキソール類およびその製造方法
|
JPH02255674A
(ja)
|
1989-03-27 |
1990-10-16 |
Fuji Photo Film Co Ltd |
4―アリールオキシ―1,3―ベンゾジオキソール類およびその製造方法
|
JPH02269352A
(ja)
|
1989-04-10 |
1990-11-02 |
Fuji Photo Film Co Ltd |
感光材料
|
JP2537682B2
(ja)
|
1989-04-21 |
1996-09-25 |
富士写真フイルム株式会社 |
3―アリ―ルオキシカテコ―ル類の製造方法
|
US5296497A
(en)
|
1989-05-16 |
1994-03-22 |
Duphar International Research B.V. |
3,4-dehydropiperidine derivatives having psychotropic activity
|
JPH03130280A
(ja)
|
1989-10-17 |
1991-06-04 |
Fuji Photo Film Co Ltd |
4―アリールオキシ―1,3―ベンゾジオキソール類の製造方法
|
JP2816492B2
(ja)
|
1990-05-23 |
1998-10-27 |
コニカ株式会社 |
ハロゲン化銀写真感光材料
|
JPH0446175A
(ja)
|
1990-06-14 |
1992-02-17 |
Fuji Photo Film Co Ltd |
5―ヒドロキシ―3,4―メチレンジオキシ安息香酸誘導体の製造法
|
JPH0641038A
(ja)
|
1992-07-17 |
1994-02-15 |
Mitsubishi Kasei Corp |
カルボン酸誘導体
|
DE4326151A1
(de)
|
1993-08-04 |
1995-02-09 |
Hoechst Ag |
Aromatische Verbindungen und ihre Verwendung in flüssigkristallinen Mischungen
|
US5629200A
(en)
|
1993-11-18 |
1997-05-13 |
Daicel Chemical Industries, Ltd. |
Production of optically active 2-amino-1-phenylethanol derivatives by asymetrical assimilation
|
US5514505A
(en)
|
1995-05-15 |
1996-05-07 |
Xerox Corporation |
Method for obtaining improved image contrast in migration imaging members
|
JP2000507212A
(ja)
|
1996-01-29 |
2000-06-13 |
ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア |
性機能不全の治療方法
|
US5968929A
(en)
|
1996-10-30 |
1999-10-19 |
Schering Corporation |
Piperazino derivatives as neurokinin antagonists
|
JPH10287654A
(ja)
|
1997-04-11 |
1998-10-27 |
Nissan Chem Ind Ltd |
ピラゾロン誘導体及び除草剤
|
DK1026950T3
(da)
|
1997-10-27 |
2006-06-26 |
Univ California |
Behandling af skizofreni med ampakiner og neuroleptika
|
EA004436B1
(ru)
|
1998-09-29 |
2004-04-29 |
Уайт Холдингз Корпорейшн |
Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ
|
EP1384713B1
(en)
*
|
1998-12-23 |
2008-10-15 |
SmithKline Beecham Corporation |
4-amino-azepan-3-one derivatives as protease inhibitors
|
US7977333B2
(en)
|
2000-04-20 |
2011-07-12 |
Bayer Healthcare Llc |
Substituted pyridines and pyridazines with angiogenesis inhibiting activity
|
US6451814B1
(en)
|
2000-07-17 |
2002-09-17 |
Wyeth |
Heterocyclic β-3 adrenergic receptor agonists
|
PL202812B1
(pl)
|
2000-08-21 |
2009-07-31 |
Astrazeneca Ab |
Pochodna chinazoliny, jej kompozycja famaceutyczna oraz jej zastosowanie
|
WO2002016327A1
(en)
|
2000-08-23 |
2002-02-28 |
The Procter & Gamble Company |
Benzimidazoles and analogues and their use as neutrophil inhibitors
|
HU230581B1
(hu)
|
2000-08-24 |
2017-01-30 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Tioflavin-származékok és alkalmazásuk az Alzheimer-kór diagnózisában és kezelésében
|
AUPR255401A0
(en)
|
2001-01-16 |
2001-02-08 |
Novogen Research Pty Ltd |
Regulation of lipids and/or bone density and compositions therefor
|
EP1368024A4
(en)
|
2001-03-16 |
2009-03-18 |
Novogen Res Pty Ltd |
TREATMENT OF RESTENOSIS
|
EP1385823B1
(en)
|
2001-04-09 |
2006-12-13 |
Chiron Corporation |
Guanidino compounds as melanocortin-4 receptor (mc4-r) agonists
|
JP4307843B2
(ja)
|
2001-04-19 |
2009-08-05 |
アストラゼネカ アクチボラグ |
キナゾリン誘導体
|
DE10148617A1
(de)
|
2001-09-25 |
2003-04-24 |
Schering Ag |
Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
|
DE10148618B4
(de)
|
2001-09-25 |
2007-05-03 |
Schering Ag |
Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
|
AUPR846401A0
(en)
|
2001-10-25 |
2001-11-15 |
Novogen Research Pty Ltd |
6-Hydroxy isoflavones, derivatives and medicaments involving same
|
CA2470427C
(en)
|
2001-12-21 |
2012-07-10 |
Cytokinetics, Incorporated |
Compositions and methods for treating heart failure
|
JP4412586B2
(ja)
|
2002-01-08 |
2010-02-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
エポネマイシンおよびエポキソマイシン類似物およびそれらの用途
|
AU2003214873A1
(en)
|
2002-01-18 |
2003-09-02 |
Ceretek Llc |
Methods of treating conditions associated with an edg receptor
|
US7196108B2
(en)
|
2002-03-08 |
2007-03-27 |
Incyte San Diego Inc. |
Bicyclic heterocycles for the treatment of diabetes and other diseases
|
JP2005528391A
(ja)
|
2002-04-09 |
2005-09-22 |
ノボゲン リサーチ ピーティーワイ リミテッド |
イソフラブ−3−エン及びイソフラバン構造を含む治療方法及び組成物
|
DE10219294A1
(de)
|
2002-04-25 |
2003-11-13 |
Schering Ag |
Substituierte N-(1,4,5,6-Tetrahydro-cyclopentapyrazol-3-yl)-Derivate, deren Herstellung und Verwendung als Arzneimittel
|
EP1532132B1
(en)
|
2002-07-29 |
2008-03-19 |
F.Hoffmann-La Roche Ag |
Novel benzodioxoles
|
AU2002951271A0
(en)
|
2002-09-06 |
2002-09-19 |
Novogen Research Pty Ltd |
Repair of dna mutagenic damage
|
CZ2005181A3
(cs)
|
2002-09-23 |
2005-08-17 |
Novogen Research Pty Ltd |
Léčba stárnutí pokožky vlivem světla a aktinického poškození pokožky
|
ES2328146T3
(es)
|
2003-07-28 |
2009-11-10 |
Merck Serono Sa |
2-imino-4-(tio)oxo-5-policiclovinilazolinas para su uso como inhibidores de p13 quinasas.
|
EP1663953A1
(en)
|
2003-09-24 |
2006-06-07 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
CA2546643A1
(en)
|
2003-11-18 |
2005-06-02 |
Novogen Research Pty Ltd |
Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
|
MXPA06005697A
(es)
|
2003-11-19 |
2006-08-17 |
Novogen Res Pty Ltd |
Composiciones y metodos para radioterapia y quimioterapia en combinacion.
|
CA2553729A1
(en)
|
2004-01-16 |
2005-08-04 |
Wyeth |
Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
|
TW200538127A
(en)
|
2004-04-07 |
2005-12-01 |
Millennium Pharm Inc |
PGD2 receptor antagonists for the treatment of inflammatory diseases
|
US20050245529A1
(en)
|
2004-04-14 |
2005-11-03 |
Boehringer Ingelheim International Gmbh |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
US7846959B2
(en)
|
2004-05-07 |
2010-12-07 |
Exelixis, Inc. |
Raf modulators and methods of use
|
US20060074102A1
(en)
|
2004-05-14 |
2006-04-06 |
Kevin Cusack |
Kinase inhibitors as therapeutic agents
|
ITMI20041347A1
(it)
|
2004-07-05 |
2004-10-05 |
Italfarmaco Spa |
Derivati di alfa-amminoacidi ad attivita'antiinfiammatoria
|
SE0401971D0
(sv)
|
2004-08-02 |
2004-08-02 |
Astrazeneca Ab |
Piperidne derivatives
|
WO2006040318A2
(en)
|
2004-10-12 |
2006-04-20 |
Applied Research Systems Ars Holding N.V. |
Pi3 kinase gamma inhibitors for the treatment of anaemia
|
SE0402635D0
(sv)
|
2004-10-29 |
2004-10-29 |
Astrazeneca Ab |
Chemical compounds
|
JP2006145294A
(ja)
|
2004-11-17 |
2006-06-08 |
Univ Nagoya |
蛍光標識を行うラベル化試薬、リガンドを表面にもつ基材の製造方法及びラベル化試薬を用いた測定方法
|
US7524870B2
(en)
|
2004-12-03 |
2009-04-28 |
Hoffmann-La Roche Inc. |
Biaryloxymethylarenecarboxylic acids as glycogen synthase activators
|
SI1859793T1
(sl)
|
2005-02-28 |
2011-08-31 |
Eisai R&D Man Co Ltd |
Nova kombinirana uporaba sulfonamidne spojine za zdravljenje raka
|
US20060223846A1
(en)
|
2005-03-08 |
2006-10-05 |
Dyatkin Alexey B |
Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
|
JP2008534565A
(ja)
|
2005-03-31 |
2008-08-28 |
アストラゼネカ アクチボラグ |
Tie2阻害活性のあるアミノピリミジン誘導体
|
CA2604836A1
(en)
|
2005-04-08 |
2006-10-19 |
Bayer Pharmaceuticals Corporation |
Pyrimidine derivatives and their use in the treatment of cancer
|
HUE031979T2
(en)
|
2005-05-17 |
2017-08-28 |
Sarcode Bioscience Inc |
Preparations and methods for treating eye disorders
|
MX2007014773A
(es)
|
2005-05-25 |
2008-02-20 |
Wyeth Corp |
Metodo para preparar 3-ciano-quinolinas e intermedios hechos de esta forma.
|
WO2006129609A1
(ja)
|
2005-05-30 |
2006-12-07 |
Shionogi & Co., Ltd. |
2-ナフチルイミノ-5,5-ジ置換-1,3-チアジン誘導体
|
MX2007015002A
(es)
|
2005-06-02 |
2008-02-15 |
Bayer Cropscience Ag |
Derivados de heteroarilo sustituidos con fenilalquilo.
|
WO2006138418A2
(en)
|
2005-06-14 |
2006-12-28 |
President And Fellows Of Harvard College |
Improvement of cognitive performance with sirtuin activators
|
CA2615403C
(en)
|
2005-07-15 |
2015-06-16 |
Amr Technology, Inc. |
Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
|
CA2616224A1
(en)
|
2005-07-21 |
2007-02-01 |
Paratek Pharmaceuticals, Inc. |
10-substituted tetracyclines and methods of use thereof
|
UA95247C2
(ru)
|
2005-08-04 |
2011-07-25 |
Янссен Фармацевтика Н.В. |
Пиримидиновые соединения как модуляторы рецептора серотонина
|
WO2007020936A1
(ja)
|
2005-08-17 |
2007-02-22 |
Daiichi Sankyo Company, Limited |
抗真菌作用二環性複素環化合物
|
WO2007081630A2
(en)
|
2005-12-21 |
2007-07-19 |
Janssen Pharmaceutica, N.V. |
Substituted pyrimidinyl kinase inhibitors
|
CN101007798B
(zh)
|
2006-01-24 |
2011-01-26 |
中国人民解放军军事医学科学院毒物药物研究所 |
苯并间二氧杂环戊烯衍生物及其制备方法和医药用途
|
EP1996180B1
(en)
|
2006-03-23 |
2011-08-03 |
Biota Europe Ltd |
Benzamide and pyridylamide derivatives as antibacterial agents
|
ATE463497T1
(de)
|
2006-05-30 |
2010-04-15 |
Neurosearch As |
Neues 1,4-diaza-bicycloä3.2.2ünonyl-oxadiazolyl- derivat und seine medizinische verwendung
|
WO2008027648A2
(en)
|
2006-06-26 |
2008-03-06 |
Case Western Reserve University |
Methods and compositions for treating pathologies associated with bdnf signaling
|
WO2008029168A2
(en)
|
2006-09-08 |
2008-03-13 |
Summit Corporation Plc |
Treatment of duchenne muscular dystrophy
|
CA2668008A1
(en)
|
2006-10-30 |
2008-05-08 |
Novogen Research Pty Ltd |
Prevention and reversal of chemotherapy-induced peripheral neuropathy
|
RU2333211C1
(ru)
|
2006-11-01 |
2008-09-10 |
Институт физиологически активных веществ Российской Академии наук |
N,n`-замещенные 3, 7-диазабицикло[3.3.1]нонаны, обладающие фармакологической активностью, фармацевтические композиции на их основе и способ их применения
|
EA017249B8
(ru)
|
2007-05-10 |
2013-01-30 |
Олбани Молекьюлар Рисерч, Инк. |
Арил- и гетероарилзамещенные тетрагидробензо-1,4-диазепины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
|
BRPI0704074B8
(pt)
|
2007-08-29 |
2021-05-25 |
Univ Estadual Paulista Julio De Mesquita Filho Unesp |
derivados piperidínicos da (-)-cassina e (-)-spectalina, composições farmacêuticas contendo os mesmos e processos para sua preparação
|
CA3105972A1
(en)
|
2007-10-19 |
2009-04-30 |
Novartis Ag |
Compositions and methods for treatment of diabetic retinopathy
|
CN102066339B
(zh)
|
2008-04-16 |
2014-09-24 |
波托拉医药品公司 |
作为syk或jak蛋白激酶抑制剂的2,6-二氨基-嘧啶-5-基甲酰胺类化合物
|
EP2307363B1
(en)
|
2008-06-23 |
2013-05-15 |
Janssen Pharmaceutica, N.V. |
Piperidyl acrylamide antagonists of ccr2
|
CA2733190A1
(en)
|
2008-08-14 |
2010-02-18 |
The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services |
Oxadiazole-2-oxides as antischistosomal agents
|
JP2010254629A
(ja)
|
2009-04-27 |
2010-11-11 |
Bayer Cropscience Ag |
光学活性アゾリン誘導体
|
EP2435046B1
(en)
|
2009-05-28 |
2013-09-04 |
Otsuka Pharmaceutical Co., Ltd. |
Heterocyclic compounds for the treatment of stress-related conditions
|
JP2012532850A
(ja)
|
2009-07-10 |
2012-12-20 |
ビバリス |
C型肝炎ns5bポリメラーゼの阻害剤としての置換ピロリジノン、その医薬組成物、およびそれらの治療上の使用
|
RU2417082C2
(ru)
|
2009-07-14 |
2011-04-27 |
Учреждение Российской Академии Наук Институт Физиологически Активных Веществ Ран (Ифав Ран) |
Средство для восстановления утраченной памяти в норме и патологии у пациентов всех возрастных групп на основе n, n'-замещенных 3, 7-диазабицикло[3.3.1]нонанов, фармацевтическая композиция на его основе и способ ее применения
|
CN102762703B
(zh)
|
2009-12-17 |
2016-12-07 |
路博润公司 |
含芳族化合物的润滑组合物
|
AU2011209051B2
(en)
|
2010-01-27 |
2015-01-15 |
AB Pharma Ltd. |
Polyheterocyclic compounds highly potent as HCV inhibitors
|
CN101851218B
(zh)
|
2010-04-27 |
2014-10-15 |
沈阳药科大学 |
4,5-二取代芳基异硒唑类衍生物及其用途
|
US20130338153A1
(en)
|
2010-06-10 |
2013-12-19 |
Afraxis, Inc. |
8-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
|
ES2526124T3
(es)
|
2010-06-16 |
2015-01-07 |
Cymabay Therapeutics, Inc. |
Agonistas del receptor GPR120 y sus usos
|
EP2598512A1
(en)
|
2010-07-28 |
2013-06-05 |
Medizinische Universität Wien |
Vinylogous chalcone derivatives and their medical use
|
US9132136B2
(en)
|
2010-08-02 |
2015-09-15 |
Hoffmann-La Roche Inc. |
Pharmaceutical combination
|
TW201225957A
(en)
|
2010-09-17 |
2012-07-01 |
Taisho Pharmaceutical Co Ltd |
Glycine transporter inhibitor
|
WO2012045196A1
(en)
|
2010-10-09 |
2012-04-12 |
Abbott Laboratories |
Phosphoglycerate kinase inhibitors
|
US8802673B2
(en)
|
2011-03-24 |
2014-08-12 |
Hoffmann-La Roche Inc |
Heterocyclic amine derivatives
|
WO2013025484A1
(en)
|
2011-08-12 |
2013-02-21 |
Lapchak Paul A |
Polyphenol analogs to treat ischemia
|
US8791108B2
(en)
|
2011-08-18 |
2014-07-29 |
Bristol-Myers Squibb Company |
Inhibitors of human immunodeficiency virus replication
|
JPWO2013065835A1
(ja)
|
2011-11-04 |
2015-04-02 |
味の素株式会社 |
糖尿病治療用医薬組成物
|
WO2013120104A2
(en)
*
|
2012-02-10 |
2013-08-15 |
Constellation Pharmaceuticals |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
US9475783B2
(en)
|
2012-03-21 |
2016-10-25 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
RU2509770C2
(ru)
|
2012-06-22 |
2014-03-20 |
Общество с ограниченной ответственностью "Молекулярные Технологии" |
Новые химические соединения производные 2,4-диамино-1,3,5-триазина для профилактики и лечения заболеваний человека и животных
|
AU2013309868A1
(en)
|
2012-08-30 |
2015-03-12 |
Nippon Shinyaku Co., Ltd. |
Pyridine derivative and medicine
|
EP2909214B1
(en)
|
2012-10-22 |
2020-07-22 |
City of Hope |
Etp derivatives
|
SG10201806965XA
(en)
|
2013-03-13 |
2018-09-27 |
Boston Biomedical Inc |
3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem cell pathway kinases for the treatment of cancer
|
EP2991963B1
(en)
|
2013-04-30 |
2021-07-07 |
Heinrich-Heine-Universität Düsseldorf |
Inhibitors of nhr2 and/or runx1/eto-tetramerization
|
KR20150027922A
(ko)
|
2013-09-04 |
2015-03-13 |
주식회사 대웅제약 |
신규한 항진균성 피리디닐하이드라자이드 유도체
|
EP3056507B1
(en)
|
2013-09-09 |
2020-09-23 |
Youngene Therapeutics Co., Ltd. |
C-aryl glucoside derivative, preparation method for same, and medical applications thereof
|
WO2015069110A1
(en)
|
2013-11-07 |
2015-05-14 |
Aapa B.V. |
Multiple d2 a(nta)gonists/h3 antagonists for treatment of cns-related disorders
|
SI3121175T1
(sl)
*
|
2014-03-17 |
2020-07-31 |
Daiichi Sankyo Company, Limited |
Derivati 1,3-benzodioksola kot EZH1 in/ali EZH2 inhibitorji
|
KR101877187B1
(ko)
|
2014-06-17 |
2018-07-10 |
화이자 인코포레이티드 |
치환된 다이하이드로이소퀴놀린온 화합물
|
AU2015313829B2
(en)
|
2014-09-11 |
2020-07-23 |
Piramal Enterprises Limited |
Fused heterocyclic compounds as GPR120 agonists
|
US20180037568A1
(en)
*
|
2015-02-13 |
2018-02-08 |
Constellation Pharmaceuticals, Inc. |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
KR102578297B1
(ko)
|
2015-07-30 |
2023-09-13 |
다이이찌 산쿄 가부시키가이샤 |
성인 t 세포 백혈병 림프종의 치료 및/또는 예방제
|
PL3378859T3
(pl)
*
|
2015-11-19 |
2020-04-30 |
Jiangsu Hengrui Medicine Co., Ltd. |
Pochodna benzofuranu, sposób jej wytwarzania i jej zastosowanie w medycynie
|
MX2018008644A
(es)
|
2016-01-13 |
2018-11-19 |
Gruenenthal Gmbh |
Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espir o-[4.5]-decano.
|
CN113896685B
(zh)
|
2016-02-09 |
2024-02-06 |
益方生物科技(上海)股份有限公司 |
吲哚胺-2,3-双加氧酶(ido)抑制剂
|
US20170355708A1
(en)
*
|
2016-06-09 |
2017-12-14 |
Cadent Therapeutics, Inc. |
Potassium channel modulators
|
ES2930092T3
(es)
|
2016-07-14 |
2022-12-07 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
CN106727549A
(zh)
|
2016-11-26 |
2017-05-31 |
李�荣 |
一种治疗抑郁症的药物
|
TW201831181A
(zh)
|
2017-01-19 |
2018-09-01 |
日商第一三共股份有限公司 |
用以用於治療htlv-1相關脊髓病之醫藥組成物
|
WO2018170513A1
(en)
|
2017-03-17 |
2018-09-20 |
Cornell University |
Compounds and compositions for inhibition and elimination of zika infection and uses for same
|
CN110869358A
(zh)
|
2017-05-25 |
2020-03-06 |
亚瑞克西斯制药公司 |
Kras的共价抑制剂
|
WO2019084271A1
(en)
|
2017-10-25 |
2019-05-02 |
Children's Medical Center Corporation |
PAPD5 INHIBITORS AND METHODS OF USE
|
GB201718285D0
(en)
|
2017-11-03 |
2017-12-20 |
Discuva Ltd |
Antibacterial Compounds
|
JP2021035913A
(ja)
|
2017-12-21 |
2021-03-04 |
石原産業株式会社 |
N−メトキシアミド化合物又はその塩、及びそれらを含有する農園芸用殺菌剤
|
CA3125731A1
(en)
|
2018-01-12 |
2019-07-18 |
KDAc Therapeutics, Inc. |
Combination of a selective histone deacetylase 3 (hdac3) inhibitor and an immunotherapy agent for the treatment of cancer
|
JP2019168611A
(ja)
|
2018-03-23 |
2019-10-03 |
株式会社Adeka |
光学フィルタ
|
US20210093591A1
(en)
|
2018-03-30 |
2021-04-01 |
San Diego State University (SDSU) Foundation, dba San Diego State University Research Foundation |
Methods for mitigating and preventing proteostasis-based injuries
|
CN111989325A
(zh)
|
2018-04-18 |
2020-11-24 |
星座制药公司 |
甲基修饰酶的调节剂、其组合物和用途
|